the prognostic impact of secondary-type mutations in patients with favorable risk aml
Published 4 months ago • 152 plays • Length 1:21Download video MP4
Download video MP3
Similar videos
-
3:18
the impact of secondary aml mutations on the prognosis of patients with npm1-mutated aml
-
2:19
secondary-type mutations do not impact the favorable prognosis in npm1-mutated aml
-
2:47
clinical and prognostic implications of wt1 mutations in de novo and r/r aml
-
1:12
varied outcomes in patients with aml harboring poor-risk cytogenetics with or without tp53 mutation
-
3:23
the prognostic impact of pre-transplant mrd-positivity in patients with aml
-
2:52
novel prognostic score for cmml patients undergoing sct
-
2:26
impact of allelic state on os in tp53-mutant aml and hr-mds
-
2:53
the prognostic impact of idh mutations and the role of idh inhibitors in mds
-
52:51
conducting a risk assessment for money laundering
-
1:02:19
immune checkpoint inhibition and novel therapies for myelodysplastic syndromes/neoplasms
-
9:38
pathology-acute myeloid leukemia | aml made easy | clinical features and diagnosis #acuteleukemias
-
1:34
advances and unmet needs in second-line treatment of dlbcl
-
5:01
novel classification system to improve post-transplant aml prognosis
-
3:21
the prognostic impact of flt3-itd and flt3-tkd in npm1-mutated aml
-
3:13
validation of 2022 diagnostic & prognostic classifications of aml
-
5:35
clinical and prognostic significance of aberrant t-cell marker expression in aml
-
3:23
the prognostic value of idh1 and idh2 in acute myeloid leukemia (aml)
-
2:39
aml complications: research into gvhd treatments
-
3:51
assessing high-risk aml
-
1:49
the prognostic value of flt3-itd residual disease in aml
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
4:20
therapy-related all: etiology, prognosis, and treatment